|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.980 HKD | +0.51% |
|
+5.88% | -27.74% |
| 17/06 | Luye Pharma Group Drug Meets Main Goal of Phase 2 Study | MT |
| 12/06 | Luye Pharma Group's Bond Buyback Undersubscribed | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LUYE PHARMA GROUP LTD. | Other Pharmaceuticals | +0.51% | +5.88% | -27.74% | -41.94% | -62.29% | 100.43Cr |  | | |
- Stock Market
- Stocks
- 2186 Stock
- Charts Luye Pharma Group Ltd.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition